Efficacy and Safety of Inhaled Triple Therapy Budesonide/Glycopyrrolate/Formoterol Fumarate Metered Dose Inhaler (BGF MDI) Versus Dual Therapies in Chinese Patients with Moderate-to-Very Severe COPD | |
Wang, C.; Yang, T.; Kang, J.; Chen, R.; Zhao, L.; He, H.; Assam, P. N.; Su, R.; Bourne, E.; Ballal, S. | |
2019 | |
会议名称 | AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE |
会议日期 | 2019-01-01 |
收录类别 | CPCI-S |
URL标识 | 查看原文 |
内容类型 | 会议论文 |
URI标识 | http://www.corc.org.cn/handle/1471x/6341008 |
专题 | 中国医学科学院 北京协和医学院 |
推荐引用方式 GB/T 7714 | Wang, C.,Yang, T.,Kang, J.,et al. Efficacy and Safety of Inhaled Triple Therapy Budesonide/Glycopyrrolate/Formoterol Fumarate Metered Dose Inhaler (BGF MDI) Versus Dual Therapies in Chinese Patients with Moderate-to-Very Severe COPD[C]. 见:AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE. 2019-01-01. |
个性服务 |
查看访问统计 |
相关权益政策 |
暂无数据 |
收藏/分享 |
除非特别说明,本系统中所有内容都受版权保护,并保留所有权利。
修改评论